2 / 10
Page 12
J Med Oncl Ther 2017 | Volume 2 Issue 4
allied
academies
Oncology and Biomarkers Summit
November 27-28, 2017 | Atlanta, USA
Annual Congress on
T
umor-educated blood platelets (TEPs) are implicated
as central players in the systemic and local responses
to tumor growth, thereby altering their RNA profile. In this
presentation, we will discuss the potential use of TEPs for
pan-cancer multiclass cancer and companion diagnostics,
enabling clinical advances in blood-based “liquid biopsies”.
Speaker Biography
Bakhos A Tannous is an Associate Professor of Neurology at Harvard Medical School
and Director for the Interdepartmental Neuroscience Center at the Massachusetts
General Hospital. He is a Member of the Dana Farber/Harvard Cancer Center and also
acts as Co-Director of the Molecular Neurogenetics Unit-East and Director of the MGH
Viral Vector Production Facility. His research interest includes novel imaging and high
throughput discovery of gene/cell/drug therapies for brain tumors, as well as blood-
based platforms for cancer molecular diagnostics. He has published >100 papers in
peer-review journals and serves as an Editorial Board Member of several journals.
e:
btannous@hms.harvard.eduBakhos A Tannous
Harvard Medical School, USA
Tumor-educated platelets: A blood-based platform for biomonitoring and
molecular cancer diagnostics